Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers 14, 3, S. 813
- Keyword
-
-
- Event
-
Veröffentlichung
- (where)
-
Greifswald
- (who)
-
Universität Greifswald
- (when)
-
2022
- Creator
-
Bekeschus, Sander
Ispirjan, Mikael
Freund, Eric
Kinnen, Frederik
Moritz, Juliane
Saadati, Fariba
Eckroth, Jacqueline
Singer, Debora
Stope, Matthias B.
Wende, Kristian
Ritter, Christoph A.
Schroeder, Henry W. S.
Marx, Sascha
- Contributor
-
Hassanein, Ahmed
- DOI
-
10.3390/cancers14030813
- URN
-
urn:nbn:de:gbv:9-opus-60780
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bekeschus, Sander
- Ispirjan, Mikael
- Freund, Eric
- Kinnen, Frederik
- Moritz, Juliane
- Saadati, Fariba
- Eckroth, Jacqueline
- Singer, Debora
- Stope, Matthias B.
- Wende, Kristian
- Ritter, Christoph A.
- Schroeder, Henry W. S.
- Marx, Sascha
- Hassanein, Ahmed
- Universität Greifswald
Time of origin
- 2022
Other Objects (12)
FAM72, Glioblastoma Multiforme (GBM) and Beyond
Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
Expressional analysis of glypican 3 and glypican 6 in glioblastoma multiforme (GBM) initiating cells : = Expressionsanalyse von Glypican 3 und Glypican 6 in Glioblastoma multiforme (GBM) initiierenden Zellen
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
GBM LOVE
GBM 530
Development, characterisation, and testing of CNS deliverable TRAIL-receptor agonists for the treatment of Glioblastoma (GBM)
Characterization and optimization of the tumor microenvironment in patient-derived organotypic slices and organoid models of glioblastoma
Gebäudemanagement (GBM) - Neuorganisation
Filmbild GbmH
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
FAM72, Glioblastoma Multiforme (GBM) and Beyond
Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
Expressional analysis of glypican 3 and glypican 6 in glioblastoma multiforme (GBM) initiating cells : = Expressionsanalyse von Glypican 3 und Glypican 6 in Glioblastoma multiforme (GBM) initiierenden Zellen
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
GBM LOVE
GBM 530
Development, characterisation, and testing of CNS deliverable TRAIL-receptor agonists for the treatment of Glioblastoma (GBM)
Characterization and optimization of the tumor microenvironment in patient-derived organotypic slices and organoid models of glioblastoma
Gebäudemanagement (GBM) - Neuorganisation
Filmbild GbmH
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
FAM72, Glioblastoma Multiforme (GBM) and Beyond
Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
Expressional analysis of glypican 3 and glypican 6 in glioblastoma multiforme (GBM) initiating cells : = Expressionsanalyse von Glypican 3 und Glypican 6 in Glioblastoma multiforme (GBM) initiierenden Zellen
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
GBM LOVE
GBM 530
Development, characterisation, and testing of CNS deliverable TRAIL-receptor agonists for the treatment of Glioblastoma (GBM)
Characterization and optimization of the tumor microenvironment in patient-derived organotypic slices and organoid models of glioblastoma
Gebäudemanagement (GBM) - Neuorganisation
Filmbild GbmH